|
|
|
Insider
Information: |
Kaplan Gilla Phd |
Relationship: |
Director |
City: |
Warren |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
104,532 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,258,820 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
104,532 |
|
|
Total
Value |
$8,258,820 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
|
2018-05-18 |
76,301 |
2015-01-02 |
0 |
Premium* |
|
Tyra Biosciences, Inc. |
TYRA |
Director |
2021-09-14 |
28,231 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TYRA |
Tyra Biosciences, Inc. |
Director |
|
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,231 |
|
- |
|
CELG |
Celgene Corp |
Director |
|
2016-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
81,119 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
333 |
83,067 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
82,734 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2010-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
685 |
685 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
685 |
5,370 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
733 |
88,485 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
733 |
81,852 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
734 |
83,801 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2013-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,033 |
22,688 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,033 |
38,721 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2014-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,033 |
39,754 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,066 |
81,574 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,068 |
83,642 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,068 |
74,586 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2011-06-03 |
4 |
OE |
$8.41 |
$33,620 |
D/D |
4,000 |
4,685 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2015-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,110 |
87,752 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,200 |
80,786 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2016-09-19 |
4 |
OE |
$29.26 |
$219,450 |
D/D |
7,500 |
79,642 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-08-02 |
4 |
S |
$134.52 |
$1,008,900 |
D/D |
(7,500) |
76,301 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2012-03-28 |
4 |
S |
$78.45 |
$627,600 |
D/D |
(8,000) |
5,370 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2012-03-28 |
4 |
OE |
$8.41 |
$67,240 |
D/D |
8,000 |
13,370 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-06-01 |
4 |
OE |
$28.97 |
$267,926 |
D/D |
9,250 |
82,359 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-09-12 |
4 |
S |
$141.56 |
$1,309,430 |
D/D |
(9,250) |
76,301 |
0 |
- |
|
CELG |
Celgene Corp |
Director |
|
2017-09-12 |
4 |
OE |
$33.88 |
$313,390 |
D/D |
9,250 |
85,551 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|